Picture of Aktis Oncology logo

AKTS — Aktis Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Akoustis Reports Record Q2 Revenue At $3.7 Mln

Jan 31 (Reuters) - Akoustis Technologies Inc  AKTS.O :
    * AKOUSTIS REPORTS RECORD REVENUE FOR SECOND QUARTER FISCAL
2022
ON 96% SEQUENTIAL GROWTH
    * Q2 REVENUE $3.7 MILLION
    * QTRLY LOSS PER SHARE $0.29
    * Q2 EARNINGS PER SHARE VIEW $-0.21, REVENUE VIEW $3.8
MILLION --
REFINITIV IBES DATA
    * QTRLY ADJUSTED LOSS PER SHARE $0.23

Source text for Eikon:  ID:nGNXblRLtT 
Further company coverage:  AKTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aktis Oncology

See all news